Pierre Legrain

Delachaux SA engages in manufacture of railway equipment. It offers rail infrastructure, rail signaling,electronic document management system, and chromium metal. The company was founded in 1902 and is headquartered in Colombes, France.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

Part of Thermo Fisher Scientific, Inc., Life Technologies BPD UK Ltd. supplies cell culture and bioprocessing systems. The company is based in Altrincham, UK.

Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Bruker Daltonics Ltd. manufactures mass spectrometry instruments and accessories for life science, pharmaceutical, biochemical, and chemical research as well as for more routine analytical tasks in forensics and food safety. It also provides nuclear, biological, and chemical detection services, with a CBRNE product line based on a broad array of technologies, including mass and ion mobility spectrometry. The company is headquartered in Coventry, UK.

INRIA Participations SAS provides management consulting services. The company was founded on April 16, 1998 and is headquartered in Le Chesnay, France.

Association CARE International is an organization founded in 1945 that is grounded in gender equality and women's empowerment. The non-profit company is based in Chatelaine, Switzerland, and has subsidiaries in Austria, Germany, and Switzerland. The Swiss company's goal is to reach a world of hope, inclusion, and social justice by tackling the underlying causes of poverty and social injustice. CARE International responds to the COVID-19 pandemic by meeting the challenge of the ever-changing crisis that continues to impact millions of people.

American Hospital of Paris provides healthcare services. It offers medical, surgical and obstetrical, check-ups, maternity, thyroid and vascular surgery services. The company was founded in 1906 and is headquartered in Neuilly-sur-Seine, France.

ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France.

Institut des Hautes Etudes pour la Science et la Technologie (IHEST) offers seminars and interventions to elected officials and public officials to promote the use of science in decision-making. The company is based in Paris, France and ultimately controlled by the Government of France. The board of directors includes 19 members, including representatives from the government and former auditors. The IHEST brings in high-level speakers from various fields to provide training to executives on economic and societal issues using scientific knowledge and collective intelligence.

InGen Biosciences SA is engaged in the development of in-vitro diagnostic products for use in medical biology laboratories. The company was founded in 1993 and it is headquartered in Chilly-Mazarin, France.

Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France.

Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.

Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.

International Society of Differentiation, Inc. engages in development, research and communication in the fields of cell and developmental biology, molecular biology and oncology. The company was founded by Jean Louis Auguste Brachet in 1971 and is headquartered in St. Paul, MN.

PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France.

Fondation Ophtalmologique Adolphe de Rothschild is a specialized hospital in Paris, FR that focuses on treating all pathologies related to the head and neck for both adults and children. The hospital has a pharmacy that ensures the supply of medicines and medical devices. The hospital also has a clinical research service that serves as a one-stop-shop for investigators and industrial or academic partners. The hospital is supported by the Edmond de Rothschild Foundations, which offer a Medical Fellowship program to support talented and promising young practitioners in their hospital-university dynamic. The CEO of the French company is Julien Gottsmann.

Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo.

Part of Vallourec SA, Vallourec Soluções Tubulares do Brasil SA is a manufacturing company founded in 2008 and based in Jeceaba, Brazil. The Brazilian company specializes in the production of hot-rolled seamless steel pipes.

Institut national des hautes études de la sécurité et de la justice engages in the provision of training to senior executives and research. It operates in the following business segments: security and justice sectors, economic intelligence and business protection, digital sovereignty and cybersecurity, crisis management, risk anticipation and, communication. The company was founded in 1989 and is headquartered in Paris, France.

Inserm-Transfert SA engages in the managements of economic and societal value creation and the transfer of knowledge. It operates in the human health innovation sector. The company was founded in 2000 and is headquartered in Paris, France.

Marochar SAS is a French company that specializes in the retail sale of hardware, paints, and glass. The private company is based in Les Sables d'Olonne, France. The company was founded in 1999, and Christine Petit has been the CEO of the company since 2011.

Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward.